By Ben Glickman Novo Nordisk is being investigated by a U.S. Senate committee for the prices of its blockbuster weight-loss drugs Ozempic and Wegovy.
The U.S. Justice Department on Wednesday accused Regeneron Pharmaceuticals of manipulating Medicare's drug-pricing process by ...
The U.S. Department of Justice has filed a complaint against Regeneron alleging that the pharma knowingly omitted credit card ...